 |
|
DAIICHI SANKYO COMPANY, LIMITED |
| code | 4568Market
| TYO1, OSA1, NGO1Category
of Business | Pharmaceuticals |
Inquiry : 3-5-1, Nihombashi-honcho, Chuo-ku, Tokyo 103-8426
[Official Homepage]
TEL : 03-6225-1111 |
 |
Corporate Presentation |
 |
|
|
|
|
| Acquisition of Majority Interest in Ranbaxy Laboratories Limited |
|
|
|
|
|
President & CEO Takashi Shoda
CEO & Managing Director of Ranbaxy Laboratories Limited Malvinder Mohan Singh
|
|
|
|
|
|
|
|
|
|
| Financial Results of FY2007 |
|
|
|
|
|
President&CEO Takashi Shoda
|
|
|
|
|
|
|
|
Representative Director and President&CEO Takashi Shoda
GEMRAD chairman John C. Alexander
Executive officer, head of Research and Development Division Kazunori Hirokawa |
|
|
|
|
|
|
| Precautions in use |
 |
|
Nomura
IR assumes no responsibility for correctness, validity or
any other nature of the contents on this server.
No act such as alteration, modification or addition to the
contents is permitted.
Since the contents on this server are not intended to solicit
investment, our company has no liability for any trouble related
to investment made by any audience based on the contents of
this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity
or any other nature of information, including its format and
details, obtained from any site linked from our site. |
|
|
|
|
|
